Publications by authors named "Evelyn Chiang"

Article Synopsis
  • AbGn-107 is an antibody-drug conjugate targeting the AG-7 antigen, found in various gastrointestinal cancers, which showed promising results in preclinical studies and led to a Phase I trial for GI cancers.
  • The trial used a 3+3 dose escalation design, enrolling 39 patients with advanced, recurrent GI cancers, focusing on safety, maximum tolerated dose, and efficacy with doses ranging from 0.1 to 1.0 mg/kg.
  • Findings indicated that AbGn-107 was generally well-tolerated with some serious side effects; one patient showed a partial response, and nearly half had stable disease, suggesting modest clinical activity and the need for further research on AG-7 as a therapeutic target.
View Article and Find Full Text PDF

Meditation apps are the most commonly used mental health apps. However, the optimal dosing of app-delivered meditation practice has not been established. We examined whether the distribution of meditation practices across a day impacted outcomes in a distressed population.

View Article and Find Full Text PDF

Objective: In workplace settings, autonomy is implicated in employee motivation as well as supervisor autonomy support. As a profession of risk, firefighters may experience greater levels of stress.

Methods: A self-determination paradigm was applied to the firefighter workplace.

View Article and Find Full Text PDF

Background: Self-determination theory has been widely applied to understanding individuals' health-related behaviors such as eating healthy foods and exercising. Different reasons for engagement are associated with varying levels of personal agency or autonomy. Authority figures in the environment can be supportive of autonomy or, in contrast, controlling.

View Article and Find Full Text PDF

Expectancy-value models of motivation have been applied to understanding children's choices in areas such as academics and sports. Here, an expectancy-value paradigm is applied to exercising (defined as engaging in physical activity). The notion of perceived cost is highlighted in particular.

View Article and Find Full Text PDF

We previously discovered a hamster monoclonal antibody, TAB4, against mouse PSGL-1/CD162 that can induce death of activated T cells. Here, we further investigated the potential of TAB4 in treating two murine models of T cell-mediated diseases. The results showed that administration of TAB4 suppressed incidence and severity of both GVHD and type I diabetes.

View Article and Find Full Text PDF

Increasing evidence has shown that death signaling in T cells is regulated in a complicated way. Molecules other than death receptors can also trigger T-cell death. Here, we demonstrate for the first time that P-selectin glycoprotein ligand-1 (PSGL-1) or CD162 molecules cross-linked by an anti-PSGL-1 monoclonal antibody, TAB4, can trigger a death signal in activated T cells.

View Article and Find Full Text PDF